|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 261 - 270 of 465:
FDALive.com to Broadcast the June 13th FDA Hearing on Zimulti
Video On Location Inc. (VOLi), the parent company to FDALive.com, is the world's leading source for FDA meeting broadcasting. FDALive.com broadcasts m...
Pro-Pharmaceuticals Submits Data to Begin a 505 Filing with the FDA for a New Formulation of Irinotecan
Pro-Pharmaceuticals, a Company “Advancing Drugs Through Glycoscience”, today announced it has submitted data to begin a filing under Section 505 (b)(2...
Aspreva Announces Fast-Track Designation Granted By The FDA For CellCept In Lupus Nephritis
Aspreva Pharmaceuticals Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for CellCept (mycoph...
FDA Announces New Advisory Committee To Address Risk Communication
The U.S. Food and Drug Administration (FDA) announced a new advisory committee designed to counsel the agency on how to strengthen the communication o...
FDA Approves Continuous 7-Day Glucose Monitoring System
The U.S. Food and Drug Administration today approved a device that measures glucose levels continuously for up to seven days in people with diabetes.W...
Avalere Health Compares FDA Review of Several Categories of Drugs Including Alzheimer's Disease
There are noticeable differences in the way the FDA reviews potential Alzheimer's disease (Alzheimer's), HIV/AIDS, and cancer therapies, says a new an...
Sage Communications Launches New Healthcare and Health/IT Division
Sage Communications, one of the fastest growing full-service marketing communications firms in Washington D.C., announced the launch of its new Health...
Shelhigh: FDA Refuses to Disclose Facts
The FDA continued its attack against Shelhigh by releasing a newscast on its website this month, again promoting its unfounded allegations against the...
FDA Approves Norditropin for Treatment Of Short Stature Associated With A Rare Genetic Disorder
Novo Nordisk announced that Norditropin (somatropin[rDNA origin] injection)received U.S. Food and Drug Administration (FDA) approval for the treatment...
FDA Approves Norditropin for Treatment Of Short Stature Associated With A Rare Genetic Disorder
Novo Nordisk announced that Norditropin (somatropin[rDNA origin] injection)received U.S. Food and Drug Administration (FDA) approval for the treatment... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |